Biolinq

Website

Biolinq Inc

45 Investors
Wearable Health Technology
SAN DIEGO, CA

Biolinq Inc. is a pioneering healthcare technology company focused on enhancing metabolic health monitoring through innovative wearable biosensors. The company's flagship product, a continuous glucose monitoring (CGM) system, aims to provide a simpler and more accessible alternative to traditional glucose monitoring solutions, significantly improving the lives of people with diabetes.

Products & Team

Continuous Glucose Monitoring System

Health MonitoringSeed

Biolinq's continuous glucose monitoring system is a state-of-the-art wearable patch that harnesses the power of tiny electrochemical sensors to non-invasively measure glucose levels from the intradermal space beneath the skin. It provides users with real-time insights into their glucose levels while simultaneously monitoring their activity levels, all through a user-friendly interface.

Value Proposition

Biolinq solves the challenges faced by those with diabetes by providing a continuous glucose monitoring solution that eliminates the need for traditional, invasive methods, enabling easier and consistent management of their health.

Pain Points

Customers face difficulties with traditional glucose monitoring methods that are invasive, painful, and cumbersome. Biolinq addresses these pain points by offering a more comfortable and accessible alternative that seamlessly integrates into daily life.

Needle-free application for ease of useSecure placement on the upper forearm for convenienceReal-time glucose monitoring for immediate awarenessIntegrated activity tracking to contextualize glucose dataOn-device display that alerts users to glucose levels within or outside target ranges
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
SAN DIEGO, CA
Primary headquarters

Funding History

Total Raised:
$90.0M
E

Equity Offering

March 2025
$100.0M
Target
Progress
90%
Raised
$90.0M
Target
$100.0M
#000168540625000001